2012-14           Project Grant, NSW Workers' Compensation Dust Disease Board, Australia.

• Fibroblast Growth Factor 9: a novel therapeutic and biomarker target in mesothelioma.

Lee YCG (PI) and Creaney J.   

Lung Institute of Western Australia, Perth, Australia.

2012-14           Project Grant, NSW Workers' Compensation Dust Disease Board, Australia.

• A multicentre randomised study comparing indwelling pleural catheter vs talc pleurodesis in  patients with mesothelioma or other malignant pleural effusions.

Fysh E, Lee YCG and Musk AW.   

Lung Institute of Western Australia, Perth, Australia.

2012                Project Grant, Sir Charles Gairdner Research Advisory Committee, Australia. 

• Biological roles of malignant pleural fluid in the carcinogenesis of mesothelioma

Lee YCG.            

Sir Charles Gairdner Hospital, Perth, Australia.

2012                Project Grant, Sir Charles Gairdner Research Advisory Committee, Australia. 

• A Phase 1, open label, non-randomised safety trial of intra-abdominal tPA and DNase in peritoneal dialysis patients with peritonitis

Chakera A, Boudville N and Lee YCG.

Sir Charles Gairdner Hospital, Australia.

2012                Project Grant, Cancer Council of Western Australia, Australia.  

• A multicentre randomized study comparing indwelling pleural catheter v talc pleurodesis in patients with a malignant pleural effusion.

Lee YCG (PI), Waterer GW, Musk AW and Millward M.   

University of Western Australia, Perth, Australia.

2012                Alan King Westcare Project Grant, Australia. 

• Translational research in pleural infection to optimize antibiotics choice and improve pus drainage

Lee YCG (PI), Kay I, Lansley S and Brown JS.  

Lung Institute of Western Australia, Perth, Australia.